Soluble p-selectin, D-dimer, and high-sensitivity C-reactive protein after acute deep vein thrombosis of the lower limb  Thomas Gremmel, MD, Cihan Ay,

Slides:



Advertisements
Similar presentations
Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:
Advertisements

Intermittent pneumatic compression of the foot and calf improves the outcome of catheter-directed thrombolysis using low-dose urokinase in patients with.
Changes in health-related quality of life after ultrasound-guided foam sclerotherapy for great and small saphenous varicose veins  Katy A.L. Darvall,
Without prejudice Journal of Vascular Surgery
Changes in health-related quality of life after ultrasound-guided foam sclerotherapy for great and small saphenous varicose veins  Katy A.L. Darvall,
Recurrent thromboembolism in patients with vena cava filters
Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: An increasing population at risk  John A. Sandoval,
Soft tissue sarcomas may present with deep vein thrombosis
Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs  Francisco Lozano, MD, PhD, Javier Trujillo-Santos,
Comparison of vein valve function following pharmacomechanical thrombolysis versus simple catheter-directed thrombolysis for iliofemoral deep vein thrombosis 
Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis  Juan Francisco Sanchez Muñoz-Torrero,
Mohammed Al-Omran, MD, MSc  Journal of Vascular Surgery 
Incidence of and risk factors for iliocaval venous obstruction in patients with active or healed venous leg ulcers  William Marston, MD, Daniel Fish,
Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein.
Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia  Louis L. Nguyen,
Symptomatic venous thromboembolism after femoral vein harvest
Michael H. Criqui, MD, MPH, Lindsey A. Ho, MPH, Julie O
Clinical evaluation of suspected deep vein thrombosis guides the decision to anticoagulate prophylactically but does not impact the decision to perform.
Postthrombotic vein wall remodeling: Preliminary observations
Deep venous thrombosis after repair of nonruptured abdominal aneurysm
A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,
The controversy of managing calf vein thrombosis
Improving retrieval rates of temporary inferior vena cava filters
Risk factors for mortality in patients with upper extremity and internal jugular deep venous thrombosis  Anil Hingorani, MD, Enrico Ascher, MD, Natalia.
Thrombolysis for deep venous thrombosis
Revision using distal inflow is a safe and effective treatment for ischemic steal syndrome and pathologic high flow after access creation  Thomas M. Loh,
Eligibility for home treatment of deep vein thrombosis: A prospective study in 202 consecutive patients  Thomas Schwarz, MD, Benjamin Schmidt, MD, Jan.
Breakthrough: Arthur Blakemore and Arthur Voorhees, Jr
Carlos Aguilar, MD, Valentin del Villar, MD 
What is the clinical utility of a 6-month computed tomography in the follow-up of endovascular aneurysm repair patients?  Michael R. Go, MD, Joel E. Barbato,
The role of tissue factor in patients undergoing open repair of ruptured and nonruptured abdominal aortic aneurysms  Simon D. Hobbs, MBChB, Paul Haggart,
Lowell S. Kabnick, MD  Journal of Vascular Surgery 
Melissa M. Garrido, PhD, Holly G
Without prejudice Journal of Vascular Surgery
D-dimer testing in the diagnosis of transfemoral pseudoaneurysm after percutaneous transluminal procedures  Matthias Hoke, MD, Renate Koppensteiner, MD,
Michael S. Conte, MD  Journal of Vascular Surgery 
Prediction of asymptomatic abdominal aortic aneurysm expansion by means of rate of variation of C-reactive protein plasma levels  Joaquin De Haro, MD,
Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs  Francisco Lozano, MD, PhD, Javier Trujillo-Santos,
Regulatory TEVAR clinical trials
Educational challenges in vascular surgery: An Australasian response
Infected aneurysm of the thoracic aorta
Challenges in analysis and interpretation of cost data in vascular surgery  Kevin Mani, MD, Jonas Lundkvist, RPh, PhD, Lars Holmberg, MD, PhD, Anders Wanhainen,
The best of times, the worst of times…
Radiation physics Journal of Vascular Surgery
Recurrent thromboembolism in patients with vena cava filters
Cryopreserved saphenous vein graft in infrainguinal bypass
The future of vascular surgery
Jayer Chung, MD, J. Gregory Modrall, MD, R. James Valentine, MD 
Refinements in the ultrasonic detection of popliteal vein reflux
Reply Journal of Vascular Surgery
Ramyar Gilani, MD, Roy K. Greenberg, MD, Douglas R. Johnston, MD 
Reviewer Acknowledgment
Proximate versus nonproximate risk factor associated primary deep venous thrombosis: Clinical spectrum and outcomes  Peter K. Henke, MD, Eric Ferguson,
Five-year outcome study of deep vein thrombosis in the lower limbs
Intermittent pneumatic compression of the foot and calf improves the outcome of catheter-directed thrombolysis using low-dose urokinase in patients with.
Activated protein C-protein C inhibitor complex: A new biological marker for aortic aneurysms  Tilo Kölbel, MD, Karin Strandberg, MD, PhD, Ingrid Mattiasson,
Changes in baroreceptor sensitivity after eversion carotid endarterectomy  Serdar Demirel, MD, Nicolas Attigah, MD, Hans Bruijnen, MD, Laura Macek, MD,
Regarding “Lunar cycles and abdominal aortic aneurysm rupture”
Endovascular repair of an acute blunt popliteal artery injury
Prevention of radiation injury from medical imaging
Bhagwan Satiani, MD, MBA, Patrick S. Vaccaro, MD, Michael R. Go, MD 
Inflammatory response in the acute phase of deep vein thrombosis
Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein.
Reply Journal of Vascular Surgery
Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass.
Ioannis Prionidis, MD, Tom F. Browne  Journal of Vascular Surgery 
Bhagwan Satiani, MD, MBA, Thomas E. Williams, MD, PhD, Michael R
Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: An increasing population at risk  John A. Sandoval,
Results of a single center vascular screening and education program
Deep venous thrombosis after repair of nonruptured abdominal aneurysm
Presentation transcript:

Soluble p-selectin, D-dimer, and high-sensitivity C-reactive protein after acute deep vein thrombosis of the lower limb  Thomas Gremmel, MD, Cihan Ay, MD, Daniela Seidinger, MD, Ingrid Pabinger, MD, Simon Panzer, MD, Renate Koppensteiner, MD  Journal of Vascular Surgery  Volume 54, Issue 6, Pages 48S-55S (December 2011) DOI: 10.1016/j.jvs.2011.05.097 Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 1 A, sP-selectin in patients and healthy controls at diagnosis of acute deep vein thrombosis. The boxes represent the IQR, the ends of the whiskers represent the lowest datum still within 1.5 IQR of the lower quartile, and the highest datum still within 1.5 IQR of the upper quartile. B, hs-CRP in patients and healthy controls at diagnosis of acute deep vein thrombosis. The boxes represent the IQR, the ends of the whiskers represent the lowest datum still within 1.5 IQR of the lower quartile, and the highest datum still within 1.5 IQR of the upper quartile. hs-CRP, High-sensitivity C-reactive protein; IQR, interquartile range; sP-selectin, soluble P-selectin. Journal of Vascular Surgery 2011 54, 48S-55SDOI: (10.1016/j.jvs.2011.05.097) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 2 A, Soluble p-selectin (sP-selectin) level of each patient at baseline (0), 1 month (1), 3 months (3), 6 months (6), and 12 months (12) in patients with oral anticoagulation (OAC) for 12 months, patients with OAC for 6 months and distal deep vein thrombosis (DVT), and patients with OAC for 6 months and proximal DVT. B, D-dimer level of each patient at baseline (0), 1 month (1), 3 months (3), 6 months (6), and 12 months (12) in patients with OAC for 12 months, patients with OAC for 6 months and distal DVT, and patients with OAC for 6 months and proximal DVT. C, High-sensitivity C-reactive protein (hs-CRP) level of each patient at baseline (0), 1 month (1), 3 months (3), 6 months (6), and 12 months (12) in patients with OAC for 12 months, patients with OAC for 6 months and distal DVT, and patients with OAC for 6 months and proximal DVT. Journal of Vascular Surgery 2011 54, 48S-55SDOI: (10.1016/j.jvs.2011.05.097) Copyright © 2011 Society for Vascular Surgery Terms and Conditions